Brief: Vaxcyte Q1 Operating Expenses USD 114.472 Million

Vaxcyte

08/05/2024 21:05

May 08 (Reuters) - Vaxcyte Q1 net income USD -95.02 million vs. IBES estimate
USD -122.5 million.
* Q1 cash & investments USD 1,899.765 million